Certified by Founder Lodge
NRG Therapeutics
United Kingdom - Stevenage, Hertfordshire
START UP
1 Disclosed Funding Rounds $67,835,242
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mitochondrial therapeutics for the treatment of neurodegenerative diseases
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 09 ,2025 | Series B | $67,835,242 |
Omega Funds
British Business Bank
Brandon Capital
M Ventures(Netherlands)
Criteria Bio Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Elysian | $6,000,000 | (Sep 9, 2025)
Astradyne | $2,351,350 | (Sep 9, 2025)
ACT-ion | $4,000,000 | (Sep 9, 2025)
SCOREalytics, Inc. | $3,000,000 | (Sep 9, 2025)
Supersonik | $5,000,000 | (Sep 9, 2025)
